Evidence map›Paper›PMID 37383896›Full record

ReviewWorld journal of clinical cases2023

Superior mesenteric artery syndrome: Diagnosis and management.

Akihiko Oka, Muyiwa Awoniyi, Nobuaki Hasegawa, Yuri Yoshida, Hiroshi Tobita, Norihisa Ishimura, Shunji Ishihara

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of clinical cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Akihiko OkaDepartment of Internal Medicine II, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan. aoka@med.shimane-u.ac.jp.
Muyiwa AwoniyiDepartment of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgery Institute, Hepatology Section, Cleveland Clinic, Cleveland, OH 44195, United States.
Nobuaki HasegawaDepartment of Internal Medicine II, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan.
Yuri YoshidaClinical Laboratory Division, Shimane University Hospital, Izumo 693-8501, Shimane, Japan.
Hiroshi TobitaDivision of Hepatology, Shimane University Hospital, Izumo 693-8501, Shimane, Japan.
Norihisa IshimuraDepartment of Internal Medicine II, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan.
Shunji IshiharaDepartment of Internal Medicine II, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan.
Shimane University · JPShimane University Hospital · JPCleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superior mesenteric artery (SMA) syndrome (also known as Wilkie's syndrome, cast syndrome, or aorto-mesenteric compass syndrome) is an obstruction of the duodenum caused by extrinsic compression between the SMA and the aorta. The median age of patients is 23 years old (range 0-91 years old) and predominant in females over males with a ratio of 3:2. The symptoms are variable, consisting of postprandial abdominal pain, nausea and vomiting, early satiety, anorexia, and weight loss and can mimic anorexia nervosa or functional dyspepsia. Because recurrent vomiting leads to aspiration pneumonia or respiratory depression via metabolic alkalosis, early diagnosis is required. The useful diagnostic modalities are computed tomography as a standard tool and ultrasonography, which has advantages in safety and capability of real-time assessments of SMA mobility and duodenum passage. The initial treatment is usually conservative, including postural change, gastroduodenal decompression, and nutrient management (success rates: 70%-80%). If conservative therapy fails, surgical treatment (

Indexed as

Aorto-mesenteric compass syndromeCast syndromeSuperior mesenteric artery syndromeWilkie’s syndrome

Identifiers

PMID37383896
PMCPMC10294176
OpenAlexW4378009714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.